InvestSMART

Archer Materials Limited (ASX: AXE) - Announcements

- Current share price for AXE : $0.165

ASX company news and announcements for Archer Materials Limited (AXE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Archer Materials Limited (AXE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Archer Materials Limited (AXE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Archer Materials Limited (AXE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$47 Results of 2024 Annual General Meeting 20 Nov 2024 4:21PM $0.305 $0.165 fallen by 45.90%
$47 AGM Presentation 20 Nov 2024 9:50AM $0.330 $0.165 fallen by 50%
$47 Chair's 2024 AGM address 20 Nov 2024 9:47AM $0.330 $0.165 fallen by 50%
$47 Investor Presentation 11 Nov 2024 11:39AM $0.300 $0.165 fallen by 45%
$47 TMR sensor project presentation 8 Nov 2024 9:25AM $0.305 $0.165 fallen by 45.90%
$47 Miniaturised Biochip gFET design improves foundry readiness 7 Nov 2024 9:18AM $0.260 $0.165 fallen by 36.54%
$47 Invitation to attend presentation 31 Oct 2024 8:19AM $0.255 $0.165 fallen by 35.29%
$47 Archer's 12CQ Quantum Project Hits Key Milestone 30 Oct 2024 8:47AM $0.230 $0.165 fallen by 28.26%
$47 Semiconductor Australia Conference - Presentation 23 Oct 2024 8:24AM $0.230 $0.165 fallen by 28.26%
$47 Notice of Annual General Meeting/Proxy Form 18 Oct 2024 3:57PM $0.250 $0.165 fallen by 34%
$47 Departure of CEO (update) 14 Oct 2024 9:38AM $0.270 $0.165 fallen by 38.89%
$47 Agreement signed with foundry to manufacture TMR sensors 10 Oct 2024 8:32AM $0.255 $0.165 fallen by 35.29%
$47 Quarterly Activity Report & Appendix 4C 4 Oct 2024 12:01PM $0.210 $0.165 fallen by 21.43%
$47 Archer develops new manufacturable carbon quantum material 30 Sep 2024 9:17AM $0.225 $0.165 fallen by 26.67%
$47 Proof of concept devices to improve 12CQ chip spin detection 3 Sep 2024 9:14AM $0.240 $0.165 fallen by 31.25%
$47 2024 Corporate Governance Statement and Appendix 4G 28 Aug 2024 1:21PM $0.275 $0.165 fallen by 40%
$47 Appendix 4E and 2024 Annual Report 28 Aug 2024 1:17PM $0.275 $0.165 fallen by 40%
$47 Biochip experiments begin to develop kidney disease testing 27 Aug 2024 8:41AM $0.255 $0.165 fallen by 35.29%
$47 New Integrated biochip gFET to bolster functionality 16 Aug 2024 9:21AM $0.235 $0.165 fallen by 29.79%
$47 Quarterly Activity Report & Appendix 4C 26 Jul 2024 8:55AM $0.285 $0.165 fallen by 42.11%
$47 New Biochip gFET test procedure and process developed 23 Jul 2024 8:33AM $0.300 $0.165 fallen by 45%
$47 Quantum technology project update 18 Jul 2024 9:16AM $0.280 $0.165 fallen by 41.07%
$47 Management restructure 15 Jul 2024 8:52AM $0.360 $0.165 fallen by 54.17%
$47 Departure of CEO 12 Jul 2024 7:09PM $0.360 $0.165 fallen by 54.17%
$47 Notification of cessation of securities - AXE 28 Jun 2024 4:41PM $0.335 $0.165 fallen by 50.75%

101 - 125 of 931 results

Page 5 of 38

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.